Frovatriptan succinate hydrate
CAS: 158930-17-7
Ref. TM-T11326
| 2mg | 35.00 € | ||
| 5mg | 52.00 € | ||
| 10mg | 87.00 € | ||
| 25mg | 142.00 € | ||
| 50mg | 204.00 € | ||
| 100mg | 301.00 € | ||
| 1ml*10 (DMSO) | 59.00 € |
Product Information
- Frovelan, Frova
- (3R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide Butanedioic Acid Monohydrate
- Frovatriptan Succinate Monohydrate
- Frovelan
- Migard
- (3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide
Frovatriptan succinate hydrate (Frova) is effective in treating the full spectrum of migraine including the associated symptoms of nausea, vomiting, photophobia, and phonophobia. Frovatriptan succinate hydrate can also be used as in mini-prophylaxis in menstrual migraine. Frovatriptan succinate hydrate is a potent, high affinity, selective and orally active 5-HT1B, HT1D receptor agonist and a moderately potent 5-HT7 receptor agonist, with pKi values of 8.6, 8.4, and 6.7, respectively.
Chemical properties
Technical inquiry about: TM-T11326 Frovatriptan succinate hydrate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
